Tag: antinuclear-antibody

Jun 03, 2026

• ANA
• antinuclear-antibody
• dengue
• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• post-dengue
• IIF
• HEp-2
• LIA
• prevalence
• healthy-population
• acute-phase
• IIFA
• FcγRIIa
• NS1
• MAS
• HLH
• macrophage-activation
• NS1-IgG-kinetics
• primary-infection
• PAIgG
• PAIgM
• ANA-negative
• polyreactive-IgM
• nuclear-antigen-consumption
• thrombocytopenia-bifurcation
• immune-complex
• anti-prM
• vaccine-design
• P311-330
• PDI
• epitope-mapping
• FcγRIIa-paradox
• anti-EC-isotype-shift
• dengue-mimickers
• false-positive-serology
• SLE-dengue-differential
• literature-review
• synthesis

Jun 03, 2026

• ANA
• antinuclear-antibody
• autoimmunity
• IIF
• HEp-2
• prevalence
• SLE
• healthy-population
• viral-infection
• acute-dengue
• LIA
• India
• polyreactive-antibodies
• post-dengue
• 6-month-follow-up
• fatigue
• PIF
• evidence-gap

Apr 19, 2026

• ANA
• antinuclear-antibody
• dengue
• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• post-dengue
• IIF
• HEp-2
• LIA
• prevalence
• healthy-population
• acute-phase
• IIFA
• FcγRIIa
• NS1
• MAS
• HLH
• macrophage-activation
• NS1-IgG-kinetics
• primary-infection
• PAIgG
• PAIgM
• ANA-negative
• Talib2013
• literature-review
• autoantigen-microarray
• nuclear-antigen-consumption
• thrombocytopenia-bifurcation
• immune-complex

Apr 17, 2026

• ANA
• antinuclear-antibody
• dengue
• seroconversion
• IgG
• IIFA
• HEp-2
• India
• Madhya-Pradesh
• post-dengue
• autoimmunity
• prospective

Apr 12, 2026

• ANA
• antinuclear-antibody
• NHANES
• prevalence
• temporal-trend
• United-States
• IIF
• HEp-2
• adolescents

Apr 12, 2026

• ANA
• antinuclear-antibody
• China
• prevalence
• healthy-population
• IIF
• HEp-2
• AMA-M2
• anti-SSA
• primary-biliary-cholangitis

Apr 12, 2026

• ANA
• antinuclear-antibody
• NHANES
• prevalence
• United-States
• sociodemographic
• immunofluorescence
• HEp-2

Apr 12, 2026

• ANA
• antinuclear-antibody
• healthy-population
• normal-range
• IIF
• HEp-2
• multicenter
• rheumatology